Literature DB >> 21508616

Tailored treatment approach for emphysematous pyelonephritis.

Baris Kuzgunbay1, Tahsin Turunc, Naime Tokmak, Tuba Turunc, Ayhan Dirim, Cem Aygun, Hakan Ozkardes.   

Abstract

OBJECTIVE: We evaluated the clinical presentation, diagnosis and management of patients presenting with emphysematous pyelonephritis (EP). PATIENTS AND METHODS: The clinical data of 24 EP patients diagnosed between 2000 and 2009 were retrospectively reviewed. The management strategies were discussed according to the severity of condition at presentation.
RESULTS: The mean age of the patients was 61.8 years. Diabetes mellitus was detected in 21 (87.5%) of them. Escherichia coli was the predominant pathogen. There were 6 patients (25%) who recovered with antibiotic treatment only (mild). Percutaneous drainage in addition to antimicrobial chemotherapy was necessary in 13 cases (54%) (moderate). The remaining 5 patients (21%) were treated by nephrectomy (severe).
CONCLUSIONS: EP is a serious infection that can display a fatal progression despite ablative treatment but there are also some cases with mild or moderate severity that can be successfully treated without nephrectomy.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21508616     DOI: 10.1159/000323604

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  8 in total

Review 1.  Prevalence and Risk Factors of Mortality in Emphysematous Pyelonephritis Patients: A Meta-Analysis.

Authors:  Xuan Thai Ngo; Tuan Thanh Nguyen; Ryan W Dobbs; Minh Sam Thai; Duc Huy Vu; Le Quy Van Dinh; Khoa Quy; Hieu Trong Le; Tien-Dat Hoang; Hanh Thi Tuyet Ngo; Trinh Ngoc Khanh Van; Ho Yee Tiong; Huy Gia Vuong
Journal:  World J Surg       Date:  2022-07-08       Impact factor: 3.282

2.  Emphysematous pyelonephritis: Six case reports and review of literature.

Authors:  Li-Ping Ma; Ning Zhou; Yan Fu; Yan Liu; Cong Wang; Bin Zhao
Journal:  World J Clin Cases       Date:  2022-04-06       Impact factor: 1.534

3.  What is the prognosis of emphysematous pyelonephritis associated with extended-spectrum beta-lactamases producing microorganisms?

Authors:  José Iván Robles-Torres; Marco Alberto Ocaña-Munguía; José Gustavo Arrambide-Herrera; Adrián Mauricio Martínez-Fernández; Rodrigo Romero-Mata; Lauro Salvador Gómez-Guerra
Journal:  Asian J Urol       Date:  2021-05-05

4.  Bilateral Emphysematous Pyelonephritis Associated with COVID Pneumonia: A Case Report.

Authors:  Slaviša Savić; Tadija Pejović; Nataša Savić
Journal:  Am J Case Rep       Date:  2022-06-27

5.  Role of Conservative Management in Emphysematous Pyelonephritis - A Retrospective Study.

Authors:  Sholay Meitei Kangjam; Keshorjit Singh Irom; Ibomcha Singh Khumallambam; Rajendra Singh Sinam
Journal:  J Clin Diagn Res       Date:  2015-11-01

Review 6.  A systematic review and meta-analysis of risk factors and treatment choices in emphysematous pyelonephritis.

Authors:  Rajeev Desai; Deepak Batura
Journal:  Int Urol Nephrol       Date:  2022-02-01       Impact factor: 2.370

Review 7.  Emphysematous pyelonephritis: Time for a management plan with an evidence-based approach.

Authors:  Omar M Aboumarzouk; Owen Hughes; Krishna Narahari; Richard Coulthard; Howard Kynaston; Piotr Chlosta; Bhaskar Somani
Journal:  Arab J Urol       Date:  2013-11-19

8.  Bilateral emphysematous pyelonephritis cured by antibiotics alone in a black African woman.

Authors:  G Asafu Adjaye Frimpong; E Aboagye; P Amankwah; J Boateng; A S B Amoako-Adu
Journal:  Radiol Case Rep       Date:  2018-06-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.